Clinical guidelines support lower blood pressure targets and active volume removal to mitigate fluid overload in older sepsis ...
Jipmer enrolls first infant in NeoSep1 international clinical trial in fight against neonatal sepsis
Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.
India is participating in the NeoSep1 clinical trial, which aims to improve treatment for drug-resistant newborn sepsis using ...
Robert Welsh on MSN
The TikTok makeup haul that separates the genuine finds from the algorithm-driven garbage
TikTok creates purchase urgency faster than any review process can keep up with — and the only honest way to find out whether ...
Researchers found that LLMs can perform accurate abstractions for complex quality measures, such as the SEP-1 measure for ...
Clariyon’s artificial intelligence (AI)-powered sepsis care agent has shown potential in improving a physician’s ability to ...
There are major updates in the 2026 SSC guideline (Table 1), which emphasize a patient-centered approach to the early identification and management of sepsis. Immediate screening with standardized ...
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be harmed? She writes the weekly AI Prognosis newsletter. Follow her on Threads, Mastodon, and ...
2026 Surviving Sepsis Campaign Guidelines and U.S. SEPSIS Act reinforce the need to close persistent therapeutic gaps in septic shock and improve survival through personalized, evidence-based ...
Theresa is the lead Morning Rounds writer, and her stories focus on gender-affirming care, reproductive health, and mental health. You can reach Theresa on Signal at theresagaff.97. Get your daily ...
Sepsis is one of the most dangerous medical conditions in the world, yet many people have never heard of it. It happens when the body has an extreme reaction to an infection, causing damage to its own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results